Biosimilars have had a disappointing start, but there are a few companies that are shaping up to do well. Subscribe ... An icon in the shape of a lightning bolt. Impact Link.

When US regulators approved a new drug called Zarxio in March, it became the first FDA-approved biosimilar: a "copy" of a medication made from living things. Drugs derived from biological ...

Despite eight cheaper biosimilar competitors, blockbuster anti-inflammatory Humira still dominates its market. What’s going on?

AbbVie's Tight Grip on Humira Market Raises Concerns About Biosimilars By Patrick Wingrove (Reuters) - AbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after ...

The first biosimilar was approved and introduced by the FDA in March of 2015 to combat high prices associated with its competitive “Branded Reference Biologic”, and since then, 56 additional ...